US SB775 | 2023-2024 | 118th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on March 14 2023 - 25% progression
Action: 2023-03-14 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on March 14 2023 - 25% progression
Action: 2023-03-14 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to provide for increased transparency in generic drug applications.
Title
Increasing Transparency in Generic Drug Applications Act
Sponsors
Sen. Margaret Hassan [D-NH] | Sen. Rand Paul [R-KY] | Sen. Mike Braun [R-IN] | Sen. John Hickenlooper [D-CO] |
History
Date | Chamber | Action |
---|---|---|
2023-03-14 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Same As/Similar To
HB3561 (Related) 2023-05-24 - Ordered to be Reported (Amended) by the Yeas and Nays: 49 - 0.
SB1114 (Related) 2023-06-22 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 108.
HB3839 (Related) 2023-06-09 - Referred to the Subcommittee on Health.
HB5378 (Related) 2023-12-11 - Motion to reconsider laid on the table Agreed to without objection.
SB1114 (Related) 2023-06-22 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 108.
HB3839 (Related) 2023-06-09 - Referred to the Subcommittee on Health.
HB5378 (Related) 2023-12-11 - Motion to reconsider laid on the table Agreed to without objection.
Subjects
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/118th-congress/senate-bill/775/all-info |
Text | https://www.congress.gov/118/bills/s775/BILLS-118s775is.pdf |